Status:
ACTIVE_NOT_RECRUITING
Breathwork-assisted Treatment for Cannabis Use Disorder
Lead Sponsor:
Elias Dakwar
Conditions:
Addiction
Substance Abuse
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The purpose of this proof-of-concept study is to evaluate the safety, feasibility and acceptability of a breathwork workshop intervention in individuals with cannabis use disorder.
Detailed Description
This study will test a 1-week breathwork workshop for treatment-seeking adults with a diagnosis of cannabis use disorder. The intervention consists of an enhanced breathing session with evocative musi...
Eligibility Criteria
Inclusion
- 18-70 years of age
- Meets Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria for active cannabis use disorder.
- Seeking treatment for their cannabis use
Exclusion
- Meets DSM-V criteria for schizophrenia or any psychotic illness or any dissociative disorder (Dissociative identity disorder, Dissociative amnesia, Depersonalization/derealization disorder).
- Active substance use disorder except for cannabis, nicotine, and caffeine.
- History of severe withdrawal symptoms (i.e withdrawal seizures).
- History of dementia, epilepsy or seizures, cardiac arrhythmia, pacemaker/defibrillator, heart failure, asthma, panic disorder and other respiratory illnesses (ie: COPD).
Key Trial Info
Start Date :
February 6 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05219825
Start Date
February 6 2022
End Date
December 31 2025
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York State Psychiatric Institute
New York, New York, United States, 10032